scholarly journals Stigma, Disclosure, and Depressive Symptoms among Informal Caregivers of People Living with HIV/AIDS

2009 ◽  
Vol 23 (8) ◽  
pp. 611-617 ◽  
Author(s):  
Mary M. Mitchell ◽  
Amy Knowlton
2013 ◽  
Vol 89 (Suppl 1) ◽  
pp. A391.1-A391
Author(s):  
C C Castrighini ◽  
R K Reis ◽  
L A S Neves ◽  
F G Morales ◽  
E Gir

2011 ◽  
Vol 19 (4) ◽  
pp. 874-881 ◽  
Author(s):  
Renata Karina Reis ◽  
Vanderley José Haas ◽  
Claudia Benedita dos Santos ◽  
Sheila Araujo Teles ◽  
Marli Teresinha Gimenez Galvão ◽  
...  

This is a cross-sectional study conducted with 228 people living with HIV/AIDS in a municipality in the State of São Paulo during 2007 and 2008. The aims of this study were to investigate the intensity of the depressive symptoms in individuals with HIV/AIDS treated at two referral units in Ribeirão Preto, Brazil, and to compare the quality of life with the different degrees of intensity of the depressive symptoms in these individuals, according to gender. Data were collected through individual interviews, using the Beck Depression Inventory and HIV/AIDS Targeted Quality of Life (HATQoL). A total of 63 (27.6%) patients with symptoms of depression (mild, moderate and severe) were detected. The women presented more severe symptoms of intensity of depression than men. Individuals with depressive symptoms presented lower scores of quality of life than individuals without these symptoms, with statistically significant differences between the means/medians in most domains of the HATQoL. Healthcare professionals should offer integral care for people with HIV/AIDS, emphasizing the depressive symptoms.


Author(s):  
Márcio José Dal-Bó ◽  
André Luciano Manoel ◽  
Arthur Onofre Beltram Filho ◽  
Bibiana Quatrin Tiellet da Silva ◽  
Yuri Souza Cardoso ◽  
...  

2005 ◽  
Vol 39 (9) ◽  
pp. 826-832 ◽  
Author(s):  
Fiona Judd ◽  
Angela Komiti ◽  
Phyllis Chua ◽  
Anne Mijch ◽  
Jennifer Hoy ◽  
...  

Objective: Existing research suggests that the rate of depressive illness and depressive symptoms are high in people living with HIV/AIDS, but investigations on the causes of depression provide conflicting results. Social, psychological and biological factors have all been suggested as possible causes of depression in people living with HIV/AIDS. The suggestion that depression may be the result of the neurotropic effects of the virus on the central nervous system leading to an ‘organic’ or secondary depression has major implications in the treatment of HIV/AIDS. The aim of the current study was to further investigate the nature and underlying aetiology of depression in people living with HIV/AIDS. Method: One hundred and twenty-nine people living with HIV/AIDS recruited for the study from outpatients clinics and primary care settings completed a range of self-report symptom measures including the Beck Depression Inventory (BDI), SF-36, SPHERE and a personality measure, the NEO Personality Inventory (NEO-PI). They also completed a battery of neuropsychological tests (CANTAB) and a structured clinical interview (SCID-DSM-IV). Medical and sociodemographic data were also recorded. Results: Approximately one-third scored ≥14 on the BDI and 27% met criteria for a current ‘mood disorder’ on the SCID. Depressive symptoms were strongly related to personality style, having a past psychiatric history and current stressful psychosocial situation. There was no association between depression and HIV disease status. There was no evidence in this study cohort of a distinct subtype of ‘organic’ or secondary depression. Conclusions: These results suggest that at least for ‘well’ people living with HIV/AIDS, there is no distinct subtype of depression and early treatment approaches can be modelled on those used for other non-HIV groups. Further longitudinal studies will be required to dissect out the multiple factors underlying depression in HIV/AIDS.


2021 ◽  
Vol 2021 ◽  
pp. 1-7
Author(s):  
Eba Abdisa ◽  
Tizita Tolesa ◽  
Muktar Abadiga

Background. Depressive symptoms are the most common mental illness among people living with HIV/AIDS. Depressive symptoms impact negatively on the course of HIV infection and can lead to suicide and increased risk of mortality when it is a severe form. Although depressive symptoms are common among HIV/AIDS patients, only a few studies have been conducted in Ethiopia and no study, particularly at Nekemte town public hospitals. Therefore, this study was aimed at assessing the prevalence and risk factors for depressive symptoms among people living with HIV/AIDS attending Nekemte town public hospitals, Western Ethiopia. Methods. An institution-based cross-sectional study design was conducted on 425 HIV/AIDS patients at Nekemte town public hospitals, from March 30 to May 30, 2019. Data were collected through interviews and patient document reviews. The nine-item Patient Health Questionnaire (PHQ-9) was used to collect information concerning depressive symptoms and was defined by a PHQ-9 score ≥ 5 . HIV stigma and discrimination scales were used to measure stigma. Social support was described by a sum score of the Oslo3 social support scale (OSS-3). The collected data was entered into EpiData Windows version 4.1 and then exported to Statistical Package for the Social Sciences (SPSS) Windows version 24.0 for analysis. All variables found to be significant at the bivariable level ( p value < 0.25) were entered into a multivariable logistic regression model. p values of <0.05 and 95% confidence level were used to determine statistical significance. Results. Out of the total of 384 study participants who participated in the study, 165 (42.96%) had depressive symptoms. Self-reported sleeping problems ( AOR = 7.04 , 95% CI: 3.23, 15.33), CD4 level of <200 ( AOR = 5.45 , 95% CI: 2.06, 14.42), poor social support ( AOR = 2.79 , 95% CI: 1.17, 6.67), and perceived stigma ( AOR = 9.11 , 95% CI: 1.17, 17.33) were significantly associated with depressive symptoms among HIV/AIDS patients at Nekemte town public hospitals. Conclusion. The level of depressive symptoms among HIV/AIDS patients in this study was high. Self-reported sleeping problems, CD4 level, social support, and perceived stigma were found to be significantly associated with depressive symptoms among HIV patients. Health care professionals should have to strengthen the linkage of mental health with antiretroviral therapy (ART) clinic to early detect and treat depressive symptoms.


Sign in / Sign up

Export Citation Format

Share Document